NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.0610
0.00 (0.00%)
At close: Aug 22, 2025
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $29.09 thousand as of August 25, 2025. Its market cap has decreased by -98.64% in one year.
Market Cap
29.09K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has decreased from 2.76M to 29.09K, a decrease of -98.95%. That is a compound annual growth rate of -28.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 29.09K | 15.09% |
| Dec 31, 2024 | 25.28K | -13.47% |
| Dec 28, 2023 | 29.21K | -94.38% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | 1.72M | -51.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |